NCT03502122

Brief Summary

This study aims to design and verify a multi-mode smart assistive device system for Stroke Rehabilitation by using EEG, fMRI, IMU and questioners

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Apr 2012

Typical duration for not_applicable stroke

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 24, 2012

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2014

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

March 31, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 18, 2018

Completed
Last Updated

July 5, 2018

Status Verified

July 1, 2018

Enrollment Period

2.1 years

First QC Date

March 31, 2018

Last Update Submit

July 2, 2018

Conditions

Keywords

strokerehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in FUGL- MEYER ASSESSMENT OF PHYSICAL PERFORMANCE (FMA)

    FUGL- MEYER ASSESSMENT OF PHYSICAL PERFORMANCE (FMA)

    pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

Secondary Outcomes (3)

  • change in upper extremity performance evaluation test for the elderly (TEMPA)

    pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

  • change in Brunnstrom stage

    pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

  • change in Wolf motor function

    pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

Study Arms (2)

VR rehabilitation

EXPERIMENTAL

Virtual Reality based rehabilitation therapy for motor function, 1 hour a time at an intensity of three times per week over 8 weeks (total, 24 sessions).

Other: VR rehabilitation for motor function

control- conventional rehabilitation

ACTIVE COMPARATOR

conventional rehabilitation therapy for motor function, 1 hour a time at an intensity of three times per week over 8 weeks (total, 24 sessions).

Other: VR rehabilitation for motor function

Interventions

rehabilitation for motor function

Also known as: VR rehabilitation therapy
VR rehabilitationcontrol- conventional rehabilitation

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the first time hemiparetic stroke;
  • diagnosis confirmed by a physician on the basis of the findings of neurological examinations and brain imaging (magnetic resonance imaging or computed tomography scan);
  • aged between 20 and 85 years;
  • Brunnstrom's stage II to V over the proximal and distal part of the upper extremity on the affected side;
  • no cognitive dysfunction, measured by the Mini-Mental State Exam (≧24; suggested by 36 with respect to age and educational level)
  • willing/able to participate and having signed an informed consent form.

You may not qualify if:

  • unstable vital sign
  • irreversible contracture over any of the joints of the affected upper extremity
  • history of surgery, fracture, arthritis, pain, or any other complications that might influence the recovery of upper extremity function like aphasia, apraxia and neglect;
  • having spasticity, as measured using the Modified Ashworth scale (score \> 2);
  • poststroke seizure;
  • heart attack within 3 months poststroke; cortical lesions in any of the five core motor areas of interest, including the bilateral M1, the bilateral PM, and the SMA.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

March 31, 2018

First Posted

April 18, 2018

Study Start

April 24, 2012

Primary Completion

May 28, 2014

Study Completion

May 28, 2014

Last Updated

July 5, 2018

Record last verified: 2018-07